When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
HPV vaccination can prevent cervical cancer. Currently, there are two vaccines focused on this virus and its most dangerous types. Both are effective against HPV 16 and 18,…
Over the last two and a half years, Stanford University researchers have been developing and improving a brain-computer interface (BCI) that allows paralyzed individuals to input data into…
Is attention-deficit/hyperactivity disorder (ADHD) underdiagnosed or overdiagnosed? The answer seems to depend on the population. A study published in the journal Pediatrics showed that minority children were less…
The trial revealed a linear correlation between higher tumor burden and anti-PD1 and anti-programmed death ligand (PD-L1) checkpoint inhibitors, explained as the immune system responding to reactivation.
For some patients, nutritional supplements can play a role in boosting the immune system and priming the body to better react to certain pathogens. Olive leaf extract has…
Virtually all cervical cancers are caused by the human papillomavirus (HPV). There are more than 200 HPV subtypes and at least 13 are carcinogenic. Two subtypes, HPV 16…
Walter H. Koch, PhD, Vice President of Global Research for Roche Molecular Systems, discusses the expansion of research on Zika virus in response to last year’s outbreak.
